首页> International journal of gynecological cancer : official journal of the International Gynecological Cancer Society> Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).

Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7).

导出原文传递

翻译打印收藏纠错

第一作者： Philipp,Harter

第一单位： *Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen; †Department of Gynecology, Charité Medical University of Berlin, Berlin; ‡Coordinating Center for Clinical Trials, University Marburg; §Department of Gynecology, Gynecologic Endocrinology and Oncology, Philipps University Marburg, Marburg; ∥Department of Obstetrics and Gynecology, Johann Wolfgang Goethe-University, Frankfurt; ¶Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck; #Department of Obstetrics and Gynecology, University of Duisburg-Essen, Essen; **Department of Gynecologic Oncology and Gynecology, Gynaekologicum Bremen, Bremen; ††Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, München; ‡‡Department of Obstetrics and Gynecology, Oberschwabenklinik Hospital St. Elisabeth Ravensburg, Ravensburg; §§Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm; ∥∥Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; ¶¶Department of Obstetrics and Gynecology, Carl Gustav Carus Technische University Dresden, Dresden; ##Gynecology Hannover, Hannover; ***Department of Obstetrics and Gynecology, Ev. Hospital Düsseldorf, Düsseldorf; †††Department of Obstetrics and Gynecology, University of Tübingen, Tübingen; and ‡‡‡Department of Obstetrics and Gynecology, University of Düsseldorf, Düsseldorf, Germany.

作者： Philipp,Harter ^[1] ; Jalid,Sehouli ; Alexander,Reuss ; Klaus,Baumann ; Lars,Hanker ; Rainer,Kimmig ; Willibald,Schröder ; Alexander,Burges ; Martina,Gropp-Meier ; Christian,Kurzeder ; Sven,Mahner ; Ulrich,Canzler ; Hans-Joachim,Lück ; Werner,Meier ; Tanja,Fehm ; Andreas,du Bois

作者单位： *Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte, Essen; †Department of Gynecology, Charité Medical University of Berlin, Berlin; ‡Coordinating Center for Clinical Trials, University Marburg; §Department of Gynecology, Gynecologic Endocrinology and Oncology, Philipps University Marburg, Marburg; ∥Department of Obstetrics and Gynecology, Johann Wolfgang Goethe-University, Frankfurt; ¶Department of Obstetrics and Gynecology, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck; #Department of Obstetrics and Gynecology, University of Duisburg-Essen, Essen; **Department of Gynecologic Oncology and Gynecology, Gynaekologicum Bremen, Bremen; ††Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, München; ‡‡Department of Obstetrics and Gynecology, Oberschwabenklinik Hospital St. Elisabeth Ravensburg, Ravensburg; §§Department of Obstetrics and Gynecology, University Hospital Ulm, Ulm; ∥∥Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg; ¶¶Department of Obstetrics and Gynecology, Carl Gustav Carus Technische University Dresden, Dresden; ##Gynecology Hannover, Hannover; ***Department of Obstetrics and Gynecology, Ev. Hospital Düsseldorf, Düsseldorf; †††Department of Obstetrics and Gynecology, University of Tübingen, Tübingen; and ‡‡‡Department of Obstetrics and Gynecology, University of Düsseldorf, Düsseldorf, Germany. ^[1]